Intco Medical directors boost direct shareholdings after entity liquidation

Intco Medical Technology Co., Ltd. announced a significant shift in shareholding for two of its directors and senior management, chen qiong and yu haisheng. The change occurred due to a non-trading securities transfer of 736,369 unrestricted shares, representing 0.1125% of the company's total share capital, from Shanghai Yingya Enterprise Management Center (Limited Partnership). This transfer was prompted by the liquidation of Shanghai Yingya, moving shares directly to the individual partners.

Before the transfer, chen qiong held 413,400 shares directly (0.0631%) and indirectly held 657,352 shares (0.1004%) through Shanghai Yingya. Post-transfer, her direct holdings increased to 1,070,752 shares, representing 0.1635% of the total share capital. Similarly, yu haisheng, who previously held 221,640 shares directly (0.0338%) and 79,017 shares indirectly (0.0121%), now directly holds 300,657 shares, accounting for 0.0459% of the total share capital.

The company confirmed that the transfer will not result in a change of control, nor will it impact the company's governance structure or ongoing operations.